Literature DB >> 12531054

Global aspects of tuberculosis in children.

M Datta1, S Swaminathan.   

Abstract

Tuberculosis (TB) in children reflects the prevalence of the disease in adults as well as current transmission rates. Africa and South-east Asia have the largest number of tuberculosis cases and the situation there has been worsened by the HIV epidemic. Children born to HIV-infected parents, whether infected or not, are at high risk of developing tuberculosis because of the increased risk of exposure to the disease. Tuberculosis is more common among the disadvantaged and vulnerable groups in each society and the impact of overcrowding, under-nutrition and poverty is particularly severe on children. Recent studies have documented the increase in the occurrence of tuberculosis in children, both in developed and developing countries. The peak age of notification of tuberculosis decreases as the incidence of the disease increases in the region. Tuberculosis infection can progress rapidly to disease, particularly in infancy and early childhood. Most of the morbidity occurs in the first few years after infection. Recently infected children and those with large tuberculin reaction (>18 mm) are at increased risk for progression and should be followed closely. Mortality from tuberculosis is also highest in early childhood, mainly due to disseminated forms like meningeal and miliary tuberculosis. Tuberculosis can be controlled either by preventing the infection from occurring or by treating early infection after it has occurred. An efficient tuberculosis control program with early detection of infectious adults and their cure is the best long-term approach to the reduction of TB disease in children. The DOTS strategy advocated by the WHO has the potential to have a significant impact on the epidemiology of tuberculosis by achieving high cure rates and thereby decreasing community transmission. BCG vaccination, through effective against disseminated forms of the disease in childhood, has very little impact on adult forms of the disease. Chemoprophylaxis or preventive therapy is effective, but difficult to implement on a mass scale and is only recommended for special high-risk groups in developing countries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12531054     DOI: 10.1053/prrv.2000.0115

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  11 in total

1.  New TB vaccine granted orphan drug status.

Authors:  T Lang; A V S Hill; H McShane; R Shah; A Towse; C Pritchard; M Garau
Journal:  BMJ       Date:  2005-12-17

2.  Epidemiology of tuberculosis in the Southeastern Iran.

Authors:  Hossein Ali Khazaei; Nima Rezaei; Gholam Reza Bagheri; Mohammad Ali Dankoub; Khalil Shahryari; Amir Tahai; Maryam Mahmoudi
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  A Five Years Study of Tuberculous Meningitis in Iran.

Authors:  Massoud Hajia; Ali Akbar Amirzargar; Mina Nazari; Neda Razavi Davodi; Morteza Karami Zarandi
Journal:  Iran J Pathol       Date:  2015

4.  Profile and outcome of childhood tuberculosis treated with DOTS--an observational study.

Authors:  Pushpa Panigatti; Vinod Hanumant Ratageri; Illalu Shivanand; P K Madhu; T A Shepur
Journal:  Indian J Pediatr       Date:  2013-07-28       Impact factor: 1.967

5.  Seasonality of tuberculosis.

Authors:  Auda Fares
Journal:  J Glob Infect Dis       Date:  2011-01

6.  High caseload of childhood tuberculosis in hospitals on Java Island, Indonesia: a cross sectional study.

Authors:  Trisasi Lestari; Ari Probandari; Anna-Karin Hurtig; Adi Utarini
Journal:  BMC Public Health       Date:  2011-10-11       Impact factor: 3.295

7.  Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation.

Authors:  Merrin E Rutherford; Rovina Ruslami; Winni Maharani; Indria Yulita; Sarah Lovell; Reinout Van Crevel; Bachti Alisjahbana; Philip C Hill
Journal:  BMC Res Notes       Date:  2012-01-06

8.  Understanding Market Size and Reporting Gaps for Paediatric TB in Indonesia, Nigeria and Pakistan: Supporting Improved Treatment of Childhood TB in the Advent of New Medicines.

Authors:  Renia Coghlan; Elizabeth Gardiner; Farhana Amanullah; Chikwe Ihekweazu; Rina Triasih; Malgorzata Grzemska; Charalambos Sismanidis
Journal:  PLoS One       Date:  2015-10-13       Impact factor: 3.240

9.  Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps.

Authors:  Devyani Deshpande; Shashikant Srivastava; Jotam G Pasipanodya; Stephen J Bush; Eric Nuermberger; Soumya Swaminathan; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

10.  Concentration-Dependent Synergy and Antagonism of Linezolid and Moxifloxacin in the Treatment of Childhood Tuberculosis: The Dynamic Duo.

Authors:  Devyani Deshpande; Shashikant Srivastava; Eric Nuermberger; Jotam G Pasipanodya; Soumya Swaminathan; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.